Neurotech International Limited

ASX:NTI Stock Report

Mkt Cap: AU$61.0m

Neurotech International Past Performance

How has Neurotech International performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-6.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: NTI is currently unprofitable.

Growing Profit Margin: NTI is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: NTI is unprofitable, and losses have increased over the past 5 years at a rate of 6.4% per year.

Accelerating Growth: Unable to compare NTI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NTI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-25.3%).


Return on Equity

High ROE: NTI has a negative Return on Equity (-235.12%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies